Results
eNauka >
Results >
Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trial
| Title: | Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trial | Authors  : | Torres, Fernando; ...; Ristić, Arsen D.   ; ...; (broj koautora 16) |
Issue Date: | 2019 | Publication: | The European respiratory journal | ISSN: | 0903-1936 European Respiratory Journal Search Idenfier |
Publisher: | Sheffield, United Kingdom : European Respiratory Society | Type: | Article | Collation: | vol. 54 br. 4 str. 1901030 | DOI: | 10.1183/13993003.01030-2019 | WoS-ID: | 000489941300009 | Scopus-ID: | 2-s2.0-85073125278 | PMID: | 31391223 | URI: | https://enauka.gov.rs/handle/123456789/815558 | URL: | https://erj.ersjournals.com/content/54/4/1901030 | Project: | Arena Pharmaceuticals, Inc. Crossref Funder Registry |
Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | 21a+M21a+ |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.